vialroom

#cagrilintide 2024-11-10

Sunday16 messages5 participantstimes are UTC
Highlights from this day
  • vienna_vial — the slower titration in here is community habit as much as anything, the trials had their own schedule 19:46
  • lot_number_lou — anyone got two Janoshik results on the same SGN lot for this 20:13
  • igf_one_ivy — genuine question added it to an existing retatrutide dose rather than starting both, which made attribution possible 20:16
  • first_and_last_four — how many weeks before you noticed anything on monotherapy 20:34
  • vialkeeper — the fullness thing is the part people describe differently, food stops being interesting rather than repellent 22:00

is the combination just the two dosed together or a single formulation

*VendorInvestigate not the other one

monotherapy here

does amylin do something about fullness that the GLP-1 doesnt

the slower titration in here is community habit as much as anything, the trials had their own schedule

VV
vienna_vial20:09

stopped for 14 months and the fullness went within a fortnight of the last dose

IO
igf_one_ivy20:16

genuine question added it to an existing retatrutide dose rather than starting both, which made attribution possible

right so CagriSema is cagrilintide with semaglutide and REDEFINE is the trial programme around it

VI
vialkeeperfounder21:44

back after 19 months, is monotherapy still a minority thing here

VI
vialkeeperfounder22:00

the fullness thing is the part people describe differently, food stops being interesting rather than repellent

Sponsored
Reference standardsSigma-Aldrich — certified reference materialsAnalytical standards and reagents for the calibration side of the work. If you are quantifying against nothing, you are not quantifying.Shop standards →